Tech Company Financing Transactions

Ouro Medicines Funding Round

New Enterprise Associates, Norwest Venture Partners and TPG Capital joined a $120 million Series A funding round for Ouro Medicines. The round was announced on 1/10/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
San Francisco, CA Undisclosed
USA

Phone

Undisclosed

Website

www.ouromedicines.com

Email Address

Not Recorded

Overview

Building the leading immune reset company. We founded Ouro Medicines to build the leading immune reset company. We tackle chronic immune-mediated diseases head-on by combining scientific expertise, a track record of advancing cell-depleting therapies through the clinic, and a robust pipeline.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jaideep Dudani

        

Browse more venture capital transactions:

Prev: 1/10/2025: Verdiva Bio venture capital transaction
Next: 1/10/2025: Overhaul venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary